Bank of America
VTAE

Bank of America’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Bank of America’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,497
Closed -$31K – 7672
2016
Q3 		$31K Sell
1,497
-706
-32% -$8.13K ﹤0.01% 5945
2016
Q2 		$24K Buy
2,203
+886
+67% +$7.58K ﹤0.01% 6173
2016
Q1 		$9K Sell
1,317
-3,078
-70% -$28K ﹤0.01% 6434
2015
Q4 		$79K Buy
4,395
+4,277
+3,625% +$58.9K ﹤0.01% 5843
2015
Q3 		$2K Sell
118
-313
-73% -$3.33K ﹤0.01% 7011
2015
Q2 		$6K Buy
431
+414
+2,435% +$5.62K ﹤0.01% 6786
2015
Q1 		$0 Buy
+17
New +$229 ﹤0.01% 7924

Bank of America's VTAE Position: Q4 2016 in Review

Bank of America sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 1,497 shares — an estimated $31K sold.

Bank of America first reported a position in VTAE in Q1 2015 and held it in 7 quarters. The position peaked at $79K in Q4 2015. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Bank of America reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Bank of America sold 1,497 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $31K.
  • Bank of America first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q1 2015 and held it in 7 quarters.
  • Bank of America's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $79K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.